Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -11.12 |
| peg ratio | 1.70 |
| price to book ratio | 2.57 |
| price to sales ratio | 1,666.20 |
| enterprise value multiple | -9.38 |
| price fair value | 2.57 |
profitability ratios | |
|---|---|
| gross profit margin | 30.28% |
| operating profit margin | -19938.65% |
| pretax profit margin | -16681.27% |
| net profit margin | -16681.27% |
| return on assets | -22.0% |
| return on equity | -25.14% |
| return on capital employed | -27.18% |
liquidity ratio | |
|---|---|
| current ratio | 29.55 |
| quick ratio | 29.55 |
| cash ratio | 8.40 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 1,214.93 |
| cash conversion cycle | -1,214.93 |
| receivables turnover | 0.00 |
| payables turnover | 0.30 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -40.79 |
| cash flow to debt ratio | -10.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.10 |
| cash per share | 6.12 |
| operating cash flow per share | -1.08 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -10.08 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -50.53 |
Frequently Asked Questions
Tyra Biosciences, Inc. (TYRA) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tyra Biosciences, Inc. (NASDAQ:TYRA)'s trailing twelve months ROE is -25.14%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tyra Biosciences, Inc. (TYRA) currently has a ROA of -22.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
TYRA reported a profit margin of -16681.27% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 29.55 in the most recent quarter. The quick ratio stood at 29.55, with a Debt/Eq ratio of 0.02.